Global Glioblastoma Multiforme Treatment Market Business insights
The global glioblastoma multiforme (GBM) treatment market, valued at USD 2.69 billion in 2023, is projected to experience significant growth, reaching USD 5.68 billion by 2031. This represents a robust compound annual growth rate (CAGR) of 9.8% over the forecast period from 2024 to 2031, according to the latest industry...